NEWS
SOPHiA GENETICS to Launch New Whole Genome Sequencing Capabilities
SOPHiA GENETICS (Nasdaq: SOPH) announced a collaboration with Microsoft and NVIDIA to launch a whole genome sequencing (WGS) analytical solution by end of 2024. The new WGS application aims to deliver fully analyzed genome insights within the same day, enhancing research, drug discovery, and clinical care. Leveraging Microsoft Azure and NVIDIA Parabricks, the solution will provide scalable and rapid genomic analysis, aiding researchers and clinicians in making data-driven decisions. The SOPHiA DDM™ platform integrates genomic data with other diagnostic modalities, aiming to support treatment planning and drug development efforts, particularly for cancer and rare genetic disorders.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
1377Followers
79Following
9866Visitors
Follow